ADIL

Adial Pharmaceuticals, Inc - Common Stock (ADIL)

About Adial Pharmaceuticals, Inc - Common Stock (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$0.28

Daily low

$0.26

Price at open

52 Week High

$1.30

52 Week Low

$0.22

Market cap

6.3M

Dividend yield

0.00%

Volume

4,297

Avg. volume

362,873

P/E ratio

-.29

Adial Pharmaceuticals, Inc - Common Stock News